Beckman Coulter, Inc. clinical trials
Acquired by Danaher Corporation, Jun 24, 2011 · source ↗
The registry lists 31 studies whose lead sponsor is Beckman Coulter, Inc.. 1 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 6, 2026.
Before and after it joined Danaher Corporation
- First submitted before Beckman Coulter, Inc. became part of Danaher Corporation
- 0
- First submitted after Beckman Coulter, Inc. became part of Danaher Corporation
- 31
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Beckman Coulter, Inc.31 studies
Something wrong with this grouping? Tell us on the Danaher Corporation page.
Studies
Recruiting first, then most recently updated. Showing 31 of 31. All Danaher Corporation studies →
- Sepsis Clinical Decision Support [CDS] Master Enrollment Study ProtocolEnrolling by invitationNCT05304728
Sponsor listed in the registry: Beckman Coulter, Inc. · First submitted after Beckman Coulter, Inc. became part of Danaher Corporation
- Access BNP Clinical Performance Evaluation: Testing and Clinical Concordance StudyCompletedNCT07217431
Sponsor listed in the registry: Beckman Coulter, Inc. · First submitted after Beckman Coulter, Inc. became part of Danaher Corporation
- Adult MDW Dual Cut-Off Accuracy StudyTerminatedNCT06885528
Sponsor listed in the registry: Beckman Coulter, Inc. · First submitted after Beckman Coulter, Inc. became part of Danaher Corporation
- Access HBV Assays - European Union (EU) Clinical Trial Protocol -CompletedNCT04904835
Sponsor listed in the registry: Beckman Coulter, Inc. · First submitted after Beckman Coulter, Inc. became part of Danaher Corporation
- MACE CDS Software Master Enrollment ProtocolWithdrawnNCT06257628
Sponsor listed in the registry: Beckman Coulter, Inc. · First submitted after Beckman Coulter, Inc. became part of Danaher Corporation
- Access MeMed BV Assay Clinical Study Collection Protocol - Infectious Adult and Pediatric CohortsCompletedNCT06379061
Sponsor listed in the registry: Beckman Coulter, Inc. · First submitted after Beckman Coulter, Inc. became part of Danaher Corporation
- Access BNP Clinical Enrollment StudyCompletedNCT06624293
Sponsor listed in the registry: Beckman Coulter, Inc. · First submitted after Beckman Coulter, Inc. became part of Danaher Corporation
- Access HIV Ag/Ab Combo Assay - European Union (EU) Clinical Trial ProtocolCompletedNCT04971343
Sponsor listed in the registry: Beckman Coulter, Inc. · First submitted after Beckman Coulter, Inc. became part of Danaher Corporation
- Clinical Trial to Evaluate MDW for Early Detection of SepsisActive, not recruitingNCT06267742
Sponsor listed in the registry: Beckman Coulter, Inc. · First submitted after Beckman Coulter, Inc. became part of Danaher Corporation
- Evaluation of ClearLLab LS Screening PanelCompletedNCT05819762
Sponsor listed in the registry: Beckman Coulter, Inc. · First submitted after Beckman Coulter, Inc. became part of Danaher Corporation
- Access Anti-HAV and Access Anti-HAV IgM Assays EU Clinical Trial Protocol (HAV-EU-11-23)CompletedNCT06289868
Sponsor listed in the registry: Beckman Coulter, Inc. · First submitted after Beckman Coulter, Inc. became part of Danaher Corporation
- A Cut-off Value Study of N-terminal Brain Natriuretic Peptide （Chemiluminescence Method）CompletedNCT06691477
Sponsor listed in the registry: Beckman Coulter, Inc. · First submitted after Beckman Coulter, Inc. became part of Danaher Corporation
- DxFLEX 10C Clinical StudyCompletedNCT05467449
Sponsor listed in the registry: Beckman Coulter, Inc. · First submitted after Beckman Coulter, Inc. became part of Danaher Corporation
- Access Natriuretic Peptide Assay(s) Pivotal - Emergency Department Subject Enrollment and Specimen CollectionCompletedNCT04169815
Sponsor listed in the registry: Beckman Coulter, Inc. · First submitted after Beckman Coulter, Inc. became part of Danaher Corporation
- Sepsis Post Market Clinical Utility Simple Endpoint Study - Indiana University HospitalCompletedNCT04819035
Sponsor listed in the registry: Beckman Coulter, Inc. · First submitted after Beckman Coulter, Inc. became part of Danaher Corporation
- Sepsis Post Market Clinical Utility Simple Endpoint Study - HUMCCompletedNCT04804306
Sponsor listed in the registry: Beckman Coulter, Inc. · First submitted after Beckman Coulter, Inc. became part of Danaher Corporation
- Feasibility Study of Hematology Parameters in COVID-19 DiseaseCompletedNCT04816630
Sponsor listed in the registry: Beckman Coulter, Inc. · First submitted after Beckman Coulter, Inc. became part of Danaher Corporation
- Access Anti-HCV Assay European Union (EU) Clinical Trial ProtocolCompletedNCT04971330
Sponsor listed in the registry: Beckman Coulter, Inc. · First submitted after Beckman Coulter, Inc. became part of Danaher Corporation
- Sepsis Post Market Observational Study and Potential Reduction of Time to Antibiotics - Washington UniversityCompletedNCT04353388
Sponsor listed in the registry: Beckman Coulter, Inc. · First submitted after Beckman Coulter, Inc. became part of Danaher Corporation
- Leukocyte MOrphology and CORticosteroids Response in SEPtic Patients (MOCORSEP)CompletedNCT04292431
Sponsor listed in the registry: Beckman Coulter, Inc. · First submitted after Beckman Coulter, Inc. became part of Danaher Corporation
- Sepsis Post Market Observational Study and Potential Reduction of Time to Antibiotics - Baylor S&WCompletedNCT04291417
Sponsor listed in the registry: Beckman Coulter, Inc. · First submitted after Beckman Coulter, Inc. became part of Danaher Corporation
- Evaluation of MDW for Early Detection of Sepsis, Clinical ValidityCompletedNCT03588325
Sponsor listed in the registry: Beckman Coulter, Inc. · First submitted after Beckman Coulter, Inc. became part of Danaher Corporation
- Evaluation of Monocyte Volume Distribution Width (MDW) for Early Detection of SepsisCompletedNCT03145428
Sponsor listed in the registry: Beckman Coulter, Inc. · First submitted after Beckman Coulter, Inc. became part of Danaher Corporation
- Evaluation of ClearLLab Leukemia and Lymphoma PanelsCompletedNCT03413644
Sponsor listed in the registry: Beckman Coulter, Inc. · First submitted after Beckman Coulter, Inc. became part of Danaher Corporation
- DxH520 Pediatric Reference Interval VerificationCompletedNCT03243266
Sponsor listed in the registry: Beckman Coulter, Inc. · First submitted after Beckman Coulter, Inc. became part of Danaher Corporation
- Evaluation of Prealbumin Levels in Men With Low-TCompletedNCT03313635
Sponsor listed in the registry: Beckman Coulter, Inc. · First submitted after Beckman Coulter, Inc. became part of Danaher Corporation
- Clinical Performance Evaluation of AMH AssayCompletedNCT03131388
Sponsor listed in the registry: Beckman Coulter, Inc. · First submitted after Beckman Coulter, Inc. became part of Danaher Corporation
- Clinical Performance Evaluation of DxN HCV AssayTerminatedNCT03125408
Sponsor listed in the registry: Beckman Coulter, Inc. · First submitted after Beckman Coulter, Inc. became part of Danaher Corporation
- Clinical Performance Evaluation of DxN HBV AssayTerminatedNCT03123159
Sponsor listed in the registry: Beckman Coulter, Inc. · First submitted after Beckman Coulter, Inc. became part of Danaher Corporation
- Clinical Performance Evaluation of DxN CMV AssayTerminatedNCT03127787
Sponsor listed in the registry: Beckman Coulter, Inc. · First submitted after Beckman Coulter, Inc. became part of Danaher Corporation
- Use of Blood Biomarkers and Biomarker Index to Aid in the Diagnosis of Obstructive Sleep Apnea (OSA)CompletedNCT03122483
Sponsor listed in the registry: Beckman Coulter, Inc. · First submitted after Beckman Coulter, Inc. became part of Danaher Corporation